Advanz Gains Temporary Block On Ocaliva’s Removal From EU Market

 
• By Andrew McConaghie
  
Primary Bilary Cholangitis
Ocaliva is for the treatment of the rare liver disease primary biliary cholangitis • Source: Shutterstock

More from Legal & IP

More from Pink Sheet